About Christopher Dewey
Christopher Dewey is an executive chairman at Potrero Medical.
Form D filings also name Christopher Dewey as a director at Dermasensor, MIVI Neuroscience and Radom.
Christopher Dewey reports to the SEC as a director, officer or major shareholder of 4 public companies, including TriSalus Life Sciences (TLSI), MedAvail (MDVL) and MAKO Surgical (MAKO).
Christopher Dewey first appears on SEC filings in 2007.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Dewey in the role, so the role may have started earlier or lasted longer.
Potrero Medical, Inc.
Executive Chairman
2024 – 2026 · Hayward, CA
Medical monitoring systems help clinicians track critically ill patients' kidney function.
TI
TriSalus Life Sciences, Inc.
Chief Executive Officer and director
2020 – 2023 · Public company (TLSI)
MI
MedAvail Holdings, Inc.
Director
2019 – 2020 · Public company (MDVL)
MC
MAKO Surgical Corp.
Director and 10% owner
2008 – 2013 · Public company (MAKO)
NC
National Holdings Corp.
Vice Chairman
2007 – 2010 · Public company (NHLD)
Key Colleagues at Startups
The people Christopher Dewey works with at each company, as listed on that company's latest Form D.
Potrero Medical, Inc. · Form D, May 29, 2026
Mark Goldwasser
Director
RR
Ram Reddy
Director
Rich Keenan
Sr. Regional Vice President of Sales
Maurice Ferre
Director
TD
Todd Dunn
CEO
MS
Mike Stansky
Director
DM
David Matlin
Director
Khalid Ghafari
Chief Financial Officer
CH
Clay Heighten
Director
Dermasensor, Inc. · Form D, Dec 5, 2024
MIVI Neuroscience, Inc. · Form D, May 24, 2024
CY
Craig Yeshion
Director
NH
Nathan Harrington
Director
TH
Tim Hauch
CFO
RS
Robert Stern
Director
RC
Robert Colloton
Executive officer and director
TW
Taylor Whitman
Director
Radom Corp · Form D, Jan 11, 2023
RB
Roman Bensen
Chief Executive Officer and director
ID
Ivan Delevic
Director
AM
Ashok Menon
Executive officer and director